Correlation Between Pharvaris and Nutra Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Nutra Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Nutra Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Nutra Pharma Corp, you can compare the effects of market volatilities on Pharvaris and Nutra Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Nutra Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Nutra Pharma.

Diversification Opportunities for Pharvaris and Nutra Pharma

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Pharvaris and Nutra is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Nutra Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nutra Pharma Corp and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Nutra Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nutra Pharma Corp has no effect on the direction of Pharvaris i.e., Pharvaris and Nutra Pharma go up and down completely randomly.

Pair Corralation between Pharvaris and Nutra Pharma

Given the investment horizon of 90 days Pharvaris is expected to generate 221.51 times less return on investment than Nutra Pharma. But when comparing it to its historical volatility, Pharvaris BV is 51.33 times less risky than Nutra Pharma. It trades about 0.06 of its potential returns per unit of risk. Nutra Pharma Corp is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  0.04  in Nutra Pharma Corp on September 3, 2024 and sell it today you would lose (0.03) from holding Nutra Pharma Corp or give up 75.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy37.17%
ValuesDaily Returns

Pharvaris BV  vs.  Nutra Pharma Corp

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
Nutra Pharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Strong
Over the last 90 days Nutra Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather weak technical indicators, Nutra Pharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pharvaris and Nutra Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and Nutra Pharma

The main advantage of trading using opposite Pharvaris and Nutra Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Nutra Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nutra Pharma will offset losses from the drop in Nutra Pharma's long position.
The idea behind Pharvaris BV and Nutra Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments